SARS-CoV-2/COVID-19 infection in pregnancy and its outcome in a rural tertiary care centre of West Bengal by Saha, Mriganka Mouli et al.
Indian Journal of Biochemistry & Biophysics 
Vol. 57, December 2020, pp. 694-700 
SARS-CoV-2/COVID-19 infection in pregnancy and its outcome in a rural 
tertiary care centre of West Bengal 
Mriganka Mouli Saha*, Subir Kumar Das, Nayan Chandra Sarkar, Rahul Chaudhuri, Sagar Gaikowad & 
Sagar Shirsath 
Department of Obstetrics and Gynaecology; & Department of Biochemistry, College of Medicine & JNM Hospital, 
The West Bengal University of Health Sciences, Kalyani, Nadia-741 235, West Bengal, India 
Received 15 August 2020; revised 02 October 2020 
SARS-CoV-2 infection in pregnancy and its adverse outcome on the mother as well on the fetus is emerging as an 
important concern, but knowledge about the prognosis is limited. In our prospective observational study total of 56 pregnant 
women admitted in the isolation ward of our institution were included. All women were presented with common symptoms 
like fever, tiredness, headache, sore throat, and cough. Three women diagnosed SARS-CoV-2/COVID-19 positive by 
Reverse Transcription Polymerase Chain Reaction (RTPCR) examination of the nasopharyngeal swab. All three neonates 
were tested negative for SARS-CoV-2 infection. The three mothers also recovered with routine care and returned home after 
7 days with advice for a safe home for further 7 days. SARS-CoV-2 infection in pregnancy mostly appears inthe later part of 
pregnancy and management is almost like the general population. There is no increased risk of severe disease during 
pregnancy. Neonates are mostly protected from disease transmission due to immune modulation during pregnancy. 
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Novel coronavirus (nCoV) infection, also known as 
coronavirus disease 2019 (COVID-19) in pregnancy is 
an important concern, but currently, limited data are 
available to predict the risk of virus infection in 
pregnancy and its adverse outcome
1
.It has been assumed 
that like another previous infection influenza (H1N1)
2,3
,
severe acute respiratory syndrome (SARS)
4
, Middle east 
respiratory syndrome (MERS), SARS-CoV-2 is also 
associated with increased risk of maternal and neonatal 
mortality and morbidity. Coronaviruses belong to the 
RNA virus family and therefore RNA dependent RNA 
polymerase (RdRPs) is essential for the life cycle of the 
virus
5
. Coronavirus is approximately 120 nm in length, 
with spikes of protein which are club- shaped and 
projected from the surface of the virion looking like 
solar ray (Fig. 1). It has four canonical structural proteins 
as described: large trans-membrane spike protein 
(S; 1160-1400 amino acid- AA), a small envelope 
protein (E; 74-109 AA), glycoprotein (M; 250 AA), 
and phosphorylated nucleocapsid (N; 500 AA)
6
. 
Common characteristics of CoVs include (1) 
replicase-transcriptase gene which is with highly 
conserved structural and accessory genes; (2) 
nonstructural genes by ribosomal frameshifting; (3) 
replicase–transcriptase polyprotein for enzymatic 
activities; and (4) downstream genes by the synthesis 
of 3′ nested sub-genomic mRNAs
7
. 
Receptors for the different human coronavirus 
(hCoV) infections are angiotensin-converting enzyme 2 
(ACE2) for SARS and dipeptidyl peptidase-4 (DPP4) 
for MERS
8,9
. The recent pandemic of SARS-CoV-2 
share the same receptor ACE2, but it has a strong 
affinity to the receptor- binding domain (RBD)
10
. The 
availability of specific receptor protein on the host cell 
surface is essential for the interaction between virion and 
host and it determines the susceptibility of the virion. 
After binding with the specific receptor viral RNA is 
being released into the cytoplasm of the host cell for the 
production of replicase polyprotein (pp) by translation 
and split into 12-15 non-speific proteins (nsps)
11
. These 
nsps alter the immune response and modulate the cell 
cycle. Subsequently, negative sense copies of both 
genomic and sub genomic RNAs are produced and act 
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and sub-genomic mRNAs. Viral N protein bind to the 
endoplasmic reticulum-golgi compartment (ERGIC)
12
. 
M protein guides the interaction with both N protein and 
S protein. The E protein is required for virus formation 
and it induces membrane curvature and prevents 
aggregation of M protein. Newly assembled virions  
are released usually within 3-4 h after initial infection
13
. 
Many pregnant women may remain asymptomatic 
and subsequently can experience only mild or 
moderate cold and flu-like symptoms like coughs, 
fever, shortness of breath, headache and loss or 
change to your sense of smell or taste and so more
14
. 
There is limited information about pregnant women 
who tested positive for the virus in their first trimester 
and who may get infected with symptoms like a high 
fever that may increase the risk of birth defects
15
. 
Limited data available on SARS-CoV-2 in pregnancy 
do not show an increased risk of severe disease in 
pregnancy
16
.The rate of caesarean section remains 
high, almost more than 60% in SARS-CoV-2 with 
pregnancy
17
. Association of co-morbidities like 
obesity, cardiac disease, and pulmonary disease 
increases the risk of disease progression to its severe 
form
18
. The objectives of this study were to evaluate 
the prevalence of clinical manifestations and maternal 
and perinatal outcomes of SARS-CoV-2 during 
pregnancy and presenting symptoms. We have also 
analysed the pregnancy outcomes along with the risk 
of transmission to neonates.  
 
Materials and Methods 
This prospective observational study included 56 
pregnant women who attended at emergency and 
antenatal out-patient Department from the Obstetrics and 
Gynaecology (OBG) Department, College of Medicine 
& JNM Hospital, The West Bengal University of Health 
Sciences, Kalyani, Nadia, West Bengal with 
suspected of SARS-CoV-2 infection. They were 
admitted in the isolation ward fulfilling the criteria 
either presence of two most/less common symptoms 
or single severe symptoms as mentioned by the World 
Health Organization (WHO)
19
. The most common 
symptoms include fever, dry cough, tiredness; Less 
common symptoms: generalized body aches, sore 
throat, diarrhea, conjunctivitis, headache, loss of taste 
or smell, rash on the skin, or discoloration of fingers 
or toes. Serious symptoms include shortness of breath, 
chest pain, loss of speech or movement. After 
admission detailed clinical history was recorded. A 
nasopharyngeal swab from subjects was taken within 
24 h of admission in the isolation ward, samples were 
transported to the COVID-19 laboratory maintaining 
a cold chain. Viral RNA was detected by Reverse 
Transcription Polymerase Chain Reaction (RT-PCR). 
RdRP gene and orf 1 gene both have to be detected 
simultaneously in the confirmatory protocol after the 
E gene is positive in screening protocol. The sequence 
RdRP_SARSr-R1 CARATGTTAAASACACTATT 
AGCATA uses 800 nM per reaction is specific for 
SARS-CoV-2, Wuhan strain COVID-19. The sample 
size was based on the number of admission in the 
hospital without any power calculation, proportion, 
and risk ratios with a 95% confidence interval  
(Table 1).  
 
Management and treatment protocol SARS-CoV-2 in 
pregnancy 
General Principles for patient management  
are mentioned in (Box 1). Specific precautionary  
measures for health care workers must be followed as 




Most of the patients were in- between the age 
group of 20-30 years with normal BMI (Table 3). No 
smokers were found in our study. Total of 11 women 
were suffering from pre-existing medical problems 
like asthma, diabetes, hypertension, and cardiac 
disease. Both primigravid and multi-gravid women 
were almost equally in our study. Only two patients 
were having a twin pregnancies. Almost two-third of 
patients were preterm and also six patients  
were admitted in the puerperal period. Women  
were presented with multiple symptoms and common 
 
 
Fig. 1 — Structure of coronavirus (SARS-CoV-2/COVID-19) 







Box 1 — General principle of management for COVD-19 patients 
1. All patients must always wear a 3-layer surgical mask after admission. 
2. No family member will be allowed in patient areas to meet the patient. 
3. Patient will not be allowed to carry any phone/mobile inside the ward along with him/her. 
4. A designated helpline will communicate with patient relatives about the patient’s condition. 
5. Separate lifts should be used to transport the patients. 
6. Patients should be placed in single rooms. If single rooms are not available, patients should be placed sufficiently apart.  
The distance between two beds should be more than one meter preferably 2 meters. 
7. All the paper works, e.g. writing notes in BHT or Treatment Cards should be done in a separate area. 
8. Avoid moving and transporting patients out of their room unless medically necessary. 
9. Clean Environmental surfaces with detergents and 1% Sodium Hypochlorite solution. 
10. Manage Laundry, Food Service, Utensils , and Medical Waste with safe routine procedures 
 
Table 1 — Precautionary management protocol 
 
 
Source: Department of Health, Government of West Bengal 
 




Table 2 — Protective measures for a health care worker 
Area  Health Caregiver/Category Risk Level Recommendation Comments 
Triage Area in OPD  
Doctors Chamber at OPD 
Doctor Sister Sanitary Staff Moderate N-95 Mask and Gloves Aerosol Generating 
Procedure Not Allowed 
OPD Patient Patient Party Low Triple Layer Medical Mask Practice Hand Hygeine 
Emergency Department 
Attending Non-SARI (Severe 
Acute Respiratory Illness) 
Doctor Sister Moderate N-95 Mask and Gloves Practice Hand Hygeine 
Emergency Department 
Attending SARI (Severe 
Acute Respiratory Illness) 
Doctor Sister High Full set of PPE Aerosol Generating 




Doctor Sister High Full set of PPE Aerosol Generating 
Procedure, allowed if 
indicated 
Critical Care Unit Doctor Sister Technician High Full set of PPE Aerosol Generating 




symptoms such as fever, tiredness, headache, sore 
throat, and cough (Fig. 2). 
 
Three SARS-CoV-2/COVID-19 positive cases were identified  
The neonates of the SARS-CoV-2/COVID-19 
positive mothers were negative on subsequent RT 
PCR examination (Table 4).  
 
Discussion 
Depending on the symptoms and clinical findings, it 
was difficult to diagnose SARS-CoV-2 infection in 
pregnancy, as most of them are nonspecific which may 
concurrently be encountered in other viral infections 
also. It has to be done based on clinical and subsequent 
detection of the viral genes on RT-PCR through 
nasopharyngeal (NP) swab
20
. Among the clinical 
symptoms in the isolation ward of our institution, the 
common symptoms were fever, tiredness, headache, 
sore throat, and cough. Other studies also depicted that 
fever is the most common symptom, followed by 





Fig. 2 — Symptoms of the patients (n=56) (single patient presents 
with multiple symptoms) 
Table 3 — Demographic characteristics of the study population 
(n=56) 
Demographic Characteristics Number of women  
(n=56) 
Age No of women (%) 
<20 7 (12.5 ) 
20-30 44 ( 78.6) 
>30 5 (8.9) 
Body mass index:  
Normal 36 (64.2) 
Overweight 15 (26.8) 
Obese 5 (9) 
Smoking  
Yes 0  
No 56 (100) 
Pre-existing medical problems  
Asthma 6 (10.7) 
Diabetes 2 (3.5) 
Hypertension 2 (3.5) 
Cardiac disease 1 (1.75) 
Parity  
Primi 27 (48.2) 
Multi 29 (51.8) 
Multiple Pregnancy 2 (3.5) 
Gestational age at admission  
<24 2 (3.5) 
24-28 4 (7) 
28-32 12 (21.4) 
32-37 21 (37.5) 
>37 11 (19.9) 
Puerperium 6 (10.7) 






Table 4 — Clinical Details and outcomes of COVID mothers (n=3) 
Parameters Case 1 Case 2 Case 3 
Identification 31 years old 3rd gravid female 26 years old female 20 years old female primigravid 
Gestational Age 36 weeks 35 weeks 5 days 39 wks 2 days 
Complaints/Issues with antepartum hemorrhage With severe anemia Lower abdominal pain and 
difficulty to pass the stool. 
Patient Vitals Pulse 84/ min, BP 110/70 mmHg, SpO2 – 
96%, mild pallor, no icterus and chest 
clear.  
Pulse 104/ min, BP 110/70 
mmHg, moderate to severe 
pallor, no icterus and chest fine 
crepitations.  
Pulse 82/min, SpO2- 98%, BP 
110/70 mmHg, mild pallor, no 
icterus and chest clear.  
Physical Inspection  Per abdomen: uterus size - 32-34 weeks. 
Adequate fetal movements and fetal heart 
rate audible and regular. . Per vaginal 
examination: on inspection no active 
bleeding, cervical dilatation 3 cm, cervix 
thick in consistency, amniotic membrane 
present , show present, no dribbling, 
station of presenting part high up. 
Per abdomen : uterus size - 34-36 
wks, adequate fetal movements, 
fetal heart rate audible and 
regular, fetal head floating. Per 
vaginal examination: cervix 
closed, cervix thick tubular, no 
show, no dribbling. 
Abdominal examination: uterus 
size – term, adequate fetal 
movements, fetal heart rate audible 
and regular. Vaginal examination: 
cervix 4 cm dilated, soft and 30% 
effaced, show present, no 
dribbling, vertex of the baby 
presenting part, and membrane 
present, station-1. 
Pre Delivery NA Patient had been transfused 7 units 
of Purified RBC and 4 units Fresh 
Frozen Plasma during the total 
hospital stay to overcome severe 
anemia and four doses of injection 
dexamethasone had been 
completed for fetal lung maturity. 
NA 
Delivery Details Delivered vaginally a healthy boy baby of 
2.75 kg following spontaneous onset of 
labour pain and the neonate was healthy 
after delivery without any complications. 
After delivery mother and baby were kept 
in separate rooms 
Six days after admission she 
underwent an elective caesarean 
section for post caesarean 
pregnancy at term after 
correction of anaemia. She 
delivered a healthy girl baby of 
2.56 kg, cried after birth with a 
good Apgar score 7/10 without 
any complications. 
Within 4 h after admission patient 
delivered vaginally, 3kg baby boy 
without any complications. During 
labour her vitals were pulse rate – 
76/min regular, BP- 100/70 
mmHg, SpO2 – 94% without 
oxygen , and Chest clear with 
bilateral broncho-vesicular  
sounds. SpO2 was monitored  
in every 30 m during intrapartum 
events 
Symptoms Fever (101.2C) onset from the next day 
of admission.  
The onset of fever on 3rd 
postoperative day. Moderate 
grade fever 102.5℃ and patient’s 
vitals were as pulse 86/ min,  
BP 116/80 mmHg,  
SpO2 – 97%. 
Dry cough for the past 4 days. 
COVID-19 Test A n asopharyngeal swab sample sent for 
RT-PCR on the same day and the report 
came as positive for SARS-CoV-
2/COVID-19. 
A nasopharyngeal swab was sent 
for RT-PCR immediately and 
within 24 h the result came as 
positive for SARS-CoV-2. 
A nasopharyngeal swab was sent 
for RT-PCR and the report came as 
positive for SARS-CoV-2 
COVID Treatment 
For Mother 
After delivery mother and baby were kept 
in separate rooms. As per the COVID 
protocol empirical antibiotic azithromycin 
and hydroxychloroquine she received. 
But both of the drugs were only used on 
the based on expecting a good recovery 
rate. These molecules are not anti-viral 
agents 
She received routine post-
operative care along with 
paracetamol for fever 
management, azithromycin as 
antibiotics.  
She received routine post natal care 
along with azithromycin.  
(Contd.) 




Table 4 — Clinical Details and outcomes of COVID mothers (n=3) (Contd.) 
Parameters Case 1 Case 2 Case 3 
Lab Tests Done Routine basic investigations such as 
Chest X Ray- brochovascular 
prominence ECG, Complete Hemogram 
and Blood Biochemistry for Sugar, 
LFT, Creatinine were performed and 
values were within normal limits. 
Routine basic investigations 
Chest X-Ray – ground glass 
opacities and subsequently 
underwent HRCT Thorax Ground 
glass; Crazy paving; Vascular 
dilatation; Traction 
bronchiectasis, ECG, Complete 
Hemogram and Blood 
Biochemistry for Sugar, LFT, 
Creatinine were performed and 
values were within normal limit. 
Complete Hemogram and Blood 
Biochemistry for Sugar, LFT, 
Creatinine were performed and 
values were within normal limit. 
COVID Test For 
Neonatal 
Neonate was tested 24 h after delivery 




Discharge Protocol She was discharged 7 days after 
delivery with negative NP swab test 
result with advice for another 7 days of 
strict safe home protocol.  
She was discharged after 14 days 
with twice tested negative for 
SARS-CoV-2 24 h apart. 
She was shifted to safe home four 
days after delivery for next 10 days 
and discharged total 14 days after 
delivery. 
 
Due to the newly evolving SARS-CoV-2 infection, 
the exact extent of the fetal adverse effect remains 
unknown. There is no data suggestive of an increased 
risk of miscarriage
22
. Presently the adverse outcomes 
associated with SARS-CoV-2 infection in the first 
trimester are also very difficult to predict due to lack of 
evidence. A few studies and case series involving the 
second and third- trimester women revealed no 
increased risk of teratogenicity
14,23
. In a study involving 
nine pregnant women with SARS-CoV-2 infection 
showing none of their babies were involved, and another 
study also showed 38 newborns of positive mothers 
were tested negative for SARS-CoV-2 infection
24
. 
Another study involving 33 pregnant women with 
SARS-CoV-2 infection found that three of the neonates 
were having a clinical signs and tested positive for 
SARS-CoV-2 infection. The patho-physiology of the 
vertical disease transmission during the womb or after 
the birth is uncertain. In pregnancy, there is a dominance 
of Th2 (T-helper cell) which protects the fetus from viral 
infection
25
.Neonates should be allowed for expressed 
breast milk feeding with proper hygiene and hand 
washing
26
. Royal College of Obstetrician and 
Gynecologists (RCOG) had reported that ~10% of 
affected pregnant mothers may require critical care and 
~40% of the mother may deliver preterm with a higher 
chance of caesarean section
27
. An optimal prenatal visit 
is the key success for successful pregnancy outcomes.  
 
Conclusion 
Pregnancy itself with its inherent immunocompromised 
state poses an increased risk of acquiring corona virus 
infection. It appears that most of the women had 
uneventful course due to their young age and absent 
comorbidities, but still it poses huge burden to the 
existing health care system. SARS-CoV-2 virus is an 
RNA virus and infection during pregnancy is to be 
diagnosed preferably with RT-PCR of the 
nasopharyngeal swab to detect RdRP and orf-
1antigen. SARS-CoV-2 infection during pregnancy is 
often present in the late gestational age and 
management almost the same as the general 
population. There is no increased risk of severe 
disease to the fetus during pregnancy, and newborn 
may show disease- free. Vertical transmission and 
neonatal COVID is still a possibility though no study 
has proven it. If neonates get infected the problem 
will multiply. Mother has to be isolated from the new-
born until the mother becomes negative two times by 
RT-PCR at 24 h apart. A separate isolation room 
should be available for the new-born. Risk of 
transmission to the caregivers and subsequently lack 
of available caregivers is a genuine concern. The 
disease itself is in a nascent state and more studies 
may unravel many mystery. An effective vaccine 
seems to be very necessary to tide over the pandemic 
situation but we have to wait for that. 
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